Batavia Biosciences’ project director, Dr. Ahd Hamidi is invited to speak at Mercks Vaccine Manufacturing Forum, 24 – 25 October 2018 in Dubai, about the latest advancements in production process intensification to support the demand for affordable vaccines. Out of approximately nine million children under the age of five that die each year, about 1.5 million die of vaccine preventable infectious diseases for which safe and effective vaccines are available. One of the main reasons why these underused vaccines are not globally used, is the relatively high cost. Further, new technologies are often proprietary and/or protected by patents and therefore not accessible for local vaccine manufacturers. Dr. Ahd Hamidi will present how a new highly intensified vaccine manufacturing platform could be able to solve these hurdles.
Link to event website.